EPM News Update
The manufacturing business of Dechra Pharmaceuticals, Dechra Pharmaceuticals Manufacturing (DPM), in Skipton, Yorkshire, UK, has initiated a significant investment programme to realise a major expansion of its Liquids, Creams and Ointments (LCO) department, with the aim of creating a globally cGMP compliant facility.
The expansion will include refurbishment of the existing building fabric, improved utilities and significant process equipment procurement. The new equipment will provide a major increase in manufacturing capability and capacity, estimated at five times the current level.
Managing Director Mike Annice commented: “Following our earlier FDA approval for solid dose production and the recent refurbishment of our injections suite, focus is now moving to the LCO department and a major expansion of this area will be carried out in the first half of 2014. This is another step to DPM becoming a global supplier of pharmaceutical products.”
Dechra Pharmaceuticals PLC, +44 1606 814730, www.dechraplc.com.